50
ACCELERATING RARE DISEASE RESEARCH BY CONTRIBUTING TO GLOBAL DATA INFRASTRUCTURE Marco Roos , acknowledging Elixir, RD-Connect, BBMRI, ODEX4All, FAIRDict and many colleagues

Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

ACCELERATING RARE DISEASE RESEARCH BY CONTRIBUTING TO GLOBAL DATA INFRASTRUCTURE

M a r c o R o o s , a c k n o w l e d g i n g E l i x i r, R D - C o n n e c t , B B M R I , O D E X 4 A l l , FA I R D i c t a n d m a n y c o l l e a g u e s

Page 2: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

2

Audience

Patient organisation

Research

Policy

Before I start…

14 June 2016

Page 3: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

3

Who is generating genomics data?

Who is managing a rare disease registry?

Who is managing a sample collection?

Before I start

14 June 2016

Page 4: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

http://platform.rd-connect.eu open for contributions

Page 5: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

5

Roles

between biology and computer science group leader Biosemantics knowledge discovery

group, Human Genetics, LUMC co-lead rare disease use case in Elixir:

European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

Who is talking…

14 June 2016

Page 6: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

6

Example: drug prioritization for Huntington’s DiseaseEleni Mina, Kristina Hettne, Eelke van der Horst, Katerina Nosikova, Elizaveta Besedina, Katy Wolstencroft , Peter-Bram ‘t Hoen, Marco Roos

8

Select genes by phenotype matching in

Monarch

Select drug compounds in OpenPHACTS

Filter on feasibility for treating HD

Prioritized drug compounds

Page 7: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

7

Example: drug prioritization for Huntington’s DiseaseEleni Mina, Kristina Hettne, Eelke van der Horst, Katerina Nosikova, Elizaveta Besedina, Katy Wolstencroft , Peter-Bram ‘t Hoen, Marco Roos

8

Select genes by phenotype matching in

Monarch

Select drug compounds in OpenPHACTS

Filter on feasibility for treating HD

Prioritized drug compounds

Eleni combines

Gene expression information from HD patientsChemical information about drug compounds

Literature (gene-disease relations) Recorded phenotypes of Huntington’s disease patients

Phenotypes of humans and model organisms (Monarch)

Page 8: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

8

Who knows the data best?

Eleni

The data generator/collector

Other

Who knows…

14 June 2016

Page 9: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

9

F: Eleni can easily find all relevant data

A: It is clear how Eleni can access the data

I: The data is interoperable with other

data sets (structure of data, not content)

R: Eleni and others can reuse the data

Proposition: data is FAIR?

14 June 2016

Page 10: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

10

Who should be responsible for making data FAIR?

Eleni

The data generator/collector

Other

Who is responsible

14 June 2016

Page 11: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

11

When data is not prepared for cross-resource analysis

11

Page 12: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

12

Back of an envelope calculation

6 months per data set

Reuse: 5x on average, 6x5=30 Months

For every RD: 6000x(6x5) = 180000 M

How much time do researchers spend on preparing data for integration

14 June 2016

Page 13: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

13

Data linkable at the source

6 months once

Reuse: 5x on average, +1M, 1x5=5 M (30)

For every RD: 6000x(6+1x5) = 66000 M

How much time do researchers spend on preparing data for integration

14 June 2016

(180000)

Page 14: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14

Benefits for cross-resource analysis

- 66% efficiency gain (more time for research)

- Researchers can start analysing 6x faster

How much time do researchers spend on preparing data for integration

14 June 2016

Page 15: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

15

Example: proof-of-concept rare disease

registries and biobanks

But how

14 June 2016

Page 16: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

16

DISCLAIMER

Demo based on dummyfied data derived

from real data. Results do not reflect

actual data.

14/06/201616

Page 17: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

17

As a researcher…

In addition, I would like to see in which

biobanks I can find the samples, the

phenotypes associated with them, and

information about the organisation(s)

behind the biobanks or registries

I would like to know the number of samples of

donors with an abnormality in head or neck in a

specific region of Italy, in order to check if

exposure to environmental factors is important

Page 18: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201618

Page 19: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201619

Page 20: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201620

Page 21: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201621

Page 22: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201622

Page 23: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201623

Page 24: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201624

Page 25: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201625

Page 26: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201626

Page 27: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201627

Page 28: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201628

Page 29: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201629

Page 30: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201630

Page 31: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

14 June 201631

Page 32: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

32

Claudio requested information that is in multiple sources

• Sample information in biobanks

• Patient information in registries

What just happened?

I would like to know the number of samples of

donors with an abnormality in head or neck in a

specific region of Italy, in order to check if

exposure to environmental factors is important

Page 33: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

33

PreFAIR data

14 June 2016

Disease Phenotype Consent code label

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood Health/medical/biomedical research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Mild to moderate developmental delay and difficulty with learning No restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood General research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Difficulties with eyesight General research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood Health/medical/biomedical research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Difficulties with eyesight No restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood General research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood No restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Difficulties with eyesight General research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Chorea Population origins/ancestry research, Other research specific restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Mild to moderate developmental delay and difficulty with learning No restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia Health/medical/biomedical research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood General research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia Health/medical/biomedical research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood Disease specific research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia Health/medical/biomedical research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Difficulties with eyesight General research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Difficulties with eyesight Population origins/ancestry research, Other research specific restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Mild to moderate developmental delay and difficulty with learning Disease specific research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia Population origins/ancestry research, Other research specific restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia Disease specific research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia No restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood Population origins/ancestry research, Other research specific restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood Disease specific research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia Disease specific research use and clinical care, Research use only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood Population origins/ancestry research, Research use only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Mild to moderate developmental delay and difficulty with learning General research use and clinical care, Research use only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Mild to moderate developmental delay and difficulty with learning General research use and clinical care, Research use only

Disease Phenotype Consent code label

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood Health/medical/biomedical research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Mild to moderate developmental delay and difficulty with learning No restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood General research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Difficulties with eyesight General research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood Health/medical/biomedical research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Difficulties with eyesight No restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood General research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood No restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Difficulties with eyesight General research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Chorea Population origins/ancestry research, Other research specific restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Mild to moderate developmental delay and difficulty with learning No restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia Health/medical/biomedical research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood General research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia Health/medical/biomedical research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood Disease specific research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia Health/medical/biomedical research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Difficulties with eyesight General research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Difficulties with eyesight Population origins/ancestry research, Other research specific restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Mild to moderate developmental delay and difficulty with learning Disease specific research use and clinical care, No “general methods” research

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia Population origins/ancestry research, Other research specific restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia Disease specific research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia No restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood Population origins/ancestry research, Other research specific restrictions

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood Disease specific research use and clinical care, Genetic studies only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Hypotonia Disease specific research use and clinical care, Research use only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Frequent infections in early childhood Population origins/ancestry research, Research use only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Mild to moderate developmental delay and difficulty with learning General research use and clinical care, Research use only

Partial deletion of the long arm of chromosome 14 (ORPHA262110)Mild to moderate developmental delay and difficulty with learning General research use and clinical care, Research use only

Page 34: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

34

Step 1: coding data

14 June 2016

Disease Phenotype Consent code

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207,HP_0002714,HP_0006101,HP_0100543HMB(CC), NMDS

ORPHA262110 HP_0100543,HP_0005469,HP_0005280,HP_0000580NRES, GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0008207,HP_0002714,HP_0006101,HP_0100543GRU(CC), NMDS

ORPHA262110 HP_0002307,HP_0001250,HP_0005469,HP_0005280,HP_0000580,HP_0000470,HP_0000316,HP_0000369,HP_0000463,HP_0000494,HP_0001252,HP_0001510GRU(CC), GSO

ORPHA262110 HP_0008207,HP_0002714,HP_0006101,HP_0100543HMB(CC), GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0008207NRES, GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207GRU(CC), GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207,HP_0002714,HP_0006101,HP_0100543NRES, NMDS

ORPHA262110 HP_0100543 GRU(CC), GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0008207,HP_0002714,HP_0006101,HP_0100543POA, RS-[XX]

ORPHA262110 HP_0002307,HP_0001250 NRES, RUO

ORPHA262110 HP_0008207,HP_0002714,HP_0006101,HP_0100543HMB(CC), GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0008207GRU(CC), NMDS

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207HMB(CC), NMDS

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207,HP_0002714,HP_0006101,HP_0100543DS-[XX](CC), NMDS

ORPHA262110 HP_0100543,HP_0005469,HP_0005280,HP_0000580,HP_0000470,HP_0000316,HP_0000369HMB(CC), NMDS

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0008207,HP_0002714,HP_0006101,HP_0100543GRU(CC), GSO

ORPHA262110 HP_0002307,HP_0001250 POA, RS-[XX]

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207,HP_0002714,HP_0006101,HP_0100543DS-[XX](CC), NMDS

ORPHA262110 HP_0100543 POA, RS-[XX]

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0008207,HP_0002714,HP_0006101,HP_0100543DS-[XX](CC), GSO

ORPHA262110 HP_0002307,HP_0001250 NRES, RS-[XX]

ORPHA262110 HP_0008207,HP_0002714,HP_0006101,HP_0100543POA, RS-[XX]

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0008207DS-[XX](CC), GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207DS-[XX](CC), RUO

Disease Phenotype Consent code

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207,HP_0002714,HP_0006101,HP_0100543HMB(CC), NMDS

ORPHA262110 HP_0100543,HP_0005469,HP_0005280,HP_0000580NRES, GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0008207,HP_0002714,HP_0006101,HP_0100543GRU(CC), NMDS

ORPHA262110 HP_0002307,HP_0001250,HP_0005469,HP_0005280,HP_0000580,HP_0000470,HP_0000316,HP_0000369,HP_0000463,HP_0000494,HP_0001252,HP_0001510GRU(CC), GSO

ORPHA262110 HP_0008207,HP_0002714,HP_0006101,HP_0100543HMB(CC), GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0008207NRES, GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207GRU(CC), GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207,HP_0002714,HP_0006101,HP_0100543NRES, NMDS

ORPHA262110 HP_0100543 GRU(CC), GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0008207,HP_0002714,HP_0006101,HP_0100543POA, RS-[XX]

ORPHA262110 HP_0002307,HP_0001250 NRES, RUO

ORPHA262110 HP_0008207,HP_0002714,HP_0006101,HP_0100543HMB(CC), GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0008207GRU(CC), NMDS

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207HMB(CC), NMDS

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207,HP_0002714,HP_0006101,HP_0100543DS-[XX](CC), NMDS

ORPHA262110 HP_0100543,HP_0005469,HP_0005280,HP_0000580,HP_0000470,HP_0000316,HP_0000369HMB(CC), NMDS

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0008207,HP_0002714,HP_0006101,HP_0100543GRU(CC), GSO

ORPHA262110 HP_0002307,HP_0001250 POA, RS-[XX]

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207,HP_0002714,HP_0006101,HP_0100543DS-[XX](CC), NMDS

ORPHA262110 HP_0100543 POA, RS-[XX]

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0008207,HP_0002714,HP_0006101,HP_0100543DS-[XX](CC), GSO

ORPHA262110 HP_0002307,HP_0001250 NRES, RS-[XX]

ORPHA262110 HP_0008207,HP_0002714,HP_0006101,HP_0100543POA, RS-[XX]

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0008207DS-[XX](CC), GSO

ORPHA262110 HP_0002307,HP_0001250,HP_0005280,HP_0002376,HP_0002650,HP_0100543,HP_0000232,HP_0000733,HP_0008207DS-[XX](CC), RUO

Page 35: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

35

Step 2: machine readable codes

14 June 2016

Disease Phenotype Primary consent code

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0000316>, <http://purl.obofoundry.org/obo/HP_0000369><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0000316>, <http://purl.obofoundry.org/obo/HP_0000369><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0000316>, <http://purl.obofoundry.org/obo/HP_0000369><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

Disease Phenotype Primary consent code

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0000316>, <http://purl.obofoundry.org/obo/HP_0000369><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0000316>, <http://purl.obofoundry.org/obo/HP_0000369><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0000316>, <http://purl.obofoundry.org/obo/HP_0000369><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

Page 36: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

36

Step 3: machine readable relations

14 June 2016

Disease Phenotype Primary consent code

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0000316>, <http://purl.obofoundry.org/obo/HP_0000369><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0000316>, <http://purl.obofoundry.org/obo/HP_0000369><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/><http://www.mylinkeddata.org/CCODE/HMB_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/NRES>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0000316>, <http://purl.obofoundry.org/obo/HP_0000369><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/DS-_XX__CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/><http://www.mylinkeddata.org/CCODE/POA>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<http://www.orpha.net/ORDO/ORPHA262110> <http://purl.obofoundry.org/obo/HP_0005469>, <http://purl.obofoundry.org/obo/HP_0005280><http://www.mylinkeddata.org/CCODE/GRU_CC>

<…>

<http://purl.obolibrary.org/obo/ERO_0002100> <http://purl.obolibrary.org/obo/RO_0002200>

“has phenotype”“has diagnosis”

Anonymous person ID

Page 37: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

37

Demonstrated answering questions

across biobanks and registries using

linkable data at the source

Data was made linkable using global

standards (ontologies) and computer

readable identifiers

Hard work at source, integration trivial

Summary

14 June 2016

Page 38: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

38

Emerging FAIR data ecosystem

Hemangiome

Osteogenesisimperfecta

Cystic Fibrosis

ChEBI

OrphaNet

UniProt

Predicted gene-disease relations

RS-virus

Epilepsy

Predicted chromatin states

Human Protein Atlas

Ring-14

Huntington’s Disease

WikiPathways

Page 39: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

39

Traditional warehouse

Hemangiome

Osteogenesisimperfecta

Cystic Fibrosis

ChEBI

OrphaNet

UniProt

Predicted gene-disease relations

RS-virus

Neck cancer

Predicted chromatin states

Human Protein Atlas

Ring-14

Huntington’s Disease

WikiPathways

Data warehouse

Page 40: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

40

Traditional warehouse

Hemangiome

Osteogenesisimperfecta

Cystic Fibrosis

ChEBI

OrphaNet

UniProt

Predicted gene-disease relations

RS-virus

Neck cancer

Predicted chromatin states

Human Protein Atlas

Ring-14

Huntington’s Disease

WikiPathways

Page 41: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

41

Emerging FAIR data ecosystem

Hemangiome

Osteogenesisimperfecta

Cystic Fibrosis

ChEBI

OrphaNet

UniProt

Predicted gene-disease relations

RS-virus

Epilepsy

Predicted chromatin states

Human Protein Atlas

Ring-14

Huntington’s Disease

Drug discovery (OpenPHACTS)

WikiPathways

Page 42: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

42

Emerging FAIR data ecosystem

Hemangiome

Osteogenesisimperfecta

Cystic Fibrosis

ChEBI

OrphaNet

UniProt

Predicted gene-disease relations

RS-virus

Epilepsy

Predicted chromatin states

Human Protein Atlas

Ring-14

Huntington’s Disease

Cystic fibrosis

WikiPathways

Page 43: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

43

Emerging FAIR data ecosystem

Hemangiome

Osteogenesisimperfecta

Cystic Fibrosis

ChEBI

OrphaNet

UniProt

Predicted gene-disease relations

RS-virus

Epilepsy

Predicted chromatin states

Human Protein Atlas

Ring-14

Huntington’s Disease

Drug repurposing for Ring-14 symptoms

WikiPathways

Page 44: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

44

Emerging FAIR data ecosystem

Hemangiome

Osteogenesisimperfecta

Cystic Fibrosis

ChEBI

OrphaNet

UniProt

Predicted gene-disease relations

RS-virus

Epilepsy

Predicted chromatin states

Human Protein Atlas

Ring-14

Huntington’s Disease

WikiPathways

No warehouse

Robust infrastructure

Page 45: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

45

Make at least 7 rare disease resources FAIR: biobanks, registries, molecular data with support from

RD-Connect, BBMRI, ADOPT, Elixir, FAIRDict, ODEX4All

Engaging with patient organisations (and vice versa)

E.g. Ring-14, Hemangiome (VSOP)

Engaging with registry companies

E.g. OpenApps, PatientCrossroads

How about you / your organisation / RD?

Next steps

14 June 2016

Page 46: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

46

Data owners bring their datae.g. rare disease registries, biobanks, omics

FAIR data experts + source data experts make data FAIR

Pre: two webinarsBYOD: 2+1 dayPost: two follow-up teleconferencesLearning experience: FAIR Data SOP

Contact DTL/Elixir-NL or Marco for BYODs and FAIR data projects

http://www.dtls.nl/fair-data/

Bring Your Own Data workshops

14 June 2016

Page 47: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

47

Registry summerschool and Bring Your Own Data workshopRome, September 26-28, 29-30

14 June 2016

https://www.elixir-

europe.org/events/rare-

disease-byod-workshop

http://www.iss.it/cnmr/

Page 48: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

48

Support from stakeholder projects to get

things started (RD-Connect, BBMRI, Elixir, and more)

Shared responsibility, including patient organisations

5% rule: 5% of every data generating project to FAIR data management European Open Science Cloud

Similar endorsement from NIH

Funding

14 June 2016

Page 49: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

Thank you

14-jun-16

49

http://www.iss.it/cnmr/

http://www.dtls.nl/fair-data/

Page 50: Accelerating rare disease research by contributing to global ......European life science data infrastructure member RD-Connect chair rare disease linked data and ontology task force

50